BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34645670)

  • 21. The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.
    Beltrán BE; Paredes S; Cotrina E; Sotomayor EM; Castillo JJ
    Leuk Res; 2018 Apr; 67():82-85. PubMed ID: 29477024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
    Ishikawa E; Kato S; Shimada K; Tanaka T; Suzuki Y; Satou A; Kohno K; Sakakibara A; Yamamura T; Nakamura M; Miyahara R; Goto H; Nakamura S; Hirooka Y
    Cancer Med; 2018 Dec; 7(12):6051-6063. PubMed ID: 30449068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of primary gastric lymphoma detected during screening for gastric cancer in Korea.
    Yang HJ; Lee C; Lim SH; Choi JM; Yang JI; Chung SJ; Choi SH; Im JP; Kim SG; Kim JS
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1572-83. PubMed ID: 26850225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.
    Xing W; Dresser K; Zhang R; Evens AM; Yu H; Woda BA; Chen BJ
    Oncotarget; 2016 Sep; 7(37):59976-59986. PubMed ID: 27527850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma.
    Torisu T; Kawano S; Miyawaki K; Yamamoto H; Ihara Y; Matsuno Y; Torisu K; Sugio T; Sasaki K; Shimakawa T; Kato K; Akashi K; Nakamura S; Kitazono T
    Hematol Oncol; 2021 Feb; 39(1):145-147. PubMed ID: 33034903
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary gastric lymphoma and Helicobacter pylori infection with gastric amyloidosis.
    Das K; Ghoshal UC; Jain M; Rastogi A; Tiwari S; Pandey R
    Indian J Gastroenterol; 2005; 24(5):220-2. PubMed ID: 16361772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
    Kwon D; Kim S; Kim PJ; Go H; Nam SJ; Paik JH; Kim YA; Kim TM; Heo DS; Kim CW; Jeon YK
    Histopathology; 2016 Jun; 68(7):1079-89. PubMed ID: 26426431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma.
    Furuse M; Kuwabara H; Ikeda N; Hattori Y; Ichikawa T; Kagawa N; Kikuta K; Tamai S; Nakada M; Wakabayashi T; Wanibuchi M; Kuroiwa T; Hirose Y; Miyatake SI
    BMC Cancer; 2020 Apr; 20(1):277. PubMed ID: 32248797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
    Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
    Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
    Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
    Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention.
    Shi Y; Zheng H; Wang M; Ding S
    Helicobacter; 2022 Apr; 27(2):e12878. PubMed ID: 35112435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
    Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
    [No Abstract]   [Full Text] [Related]  

  • 38. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
    Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
    Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.
    Sorigue M; Garcia O; Baptista MJ; Sancho JM; Tapia G; Mate JL; Feliu E; Navarro JT; Ribera JM
    Med Clin (Barc); 2017 Mar; 148(6):243-249. PubMed ID: 28038857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
    Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.